These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6460248)

  • 21. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of CD25- regulatory T cells following heart transplantation: evidence for transfer of long-term survival.
    Degauque N; Lair D; Braudeau C; Haspot F; Sébille F; Dupont A; Merieau E; Brouard S; Soulillou JP
    Eur J Immunol; 2007 Jan; 37(1):147-56. PubMed ID: 17171754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and local immune responses in allograft tolerance following swine liver transplantation.
    Inagaki M; Sakagami K; Oiwa T; Takasu S; Haisa M; Hasuoka H; Kurozumi Y; Miyoshi K; Kobayashi N; Saito S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):561-4. PubMed ID: 1824992
    [No Abstract]   [Full Text] [Related]  

  • 25. Donor-specific suppressor cells in renal allograft recipients: technical aspects and clinical studies.
    Dossetor JB; Liburd EM; Kovithavongs T; Pazderka F; Bettcher KB
    Transplant Proc; 1981 Sep; 13(3):1645-8. PubMed ID: 6458133
    [No Abstract]   [Full Text] [Related]  

  • 26. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune tolerance of intestinal allografts in the rat.
    Harmel RP; Tutschka PJ; Sonnino RE; Teitelbaum DH
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2883-4. PubMed ID: 2523163
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation tolerance mediated by regulatory T cells in mice.
    Feng NH; Wu HF; Wu J; Zhang W; Sui YG; He HG; Zhang CL; Zheng JS
    Chin Med J (Engl); 2004 Aug; 117(8):1184-9. PubMed ID: 15361292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
    Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
    Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression and stimulation of T cell clones of renal transplant recipients by autologous post-transplant sera: a role for regulatory antibodies.
    Daniel V; Opelz G
    Transplant Proc; 1987 Oct; 19(5):4210-3. PubMed ID: 2960049
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
    Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in human regulatory T lymphocytes subpopulations after renal allografting.
    Ellis TM; Lee HM; Mohanakumar T
    J Immunol; 1981 Dec; 127(6):2199-203. PubMed ID: 6457868
    [No Abstract]   [Full Text] [Related]  

  • 36. Transplantation tolerance: a journey from ignorance to memory.
    Lakkis FG
    Nephrol Dial Transplant; 2003 Oct; 18(10):1979-82. PubMed ID: 13679469
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient.
    Zheng SG; Meng L; Wang JH; Watanabe M; Barr ML; Cramer DV; Gray JD; Horwitz DA
    Int Immunol; 2006 Feb; 18(2):279-89. PubMed ID: 16415106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological considerations in renal transplantation in young patients.
    Roth D; Freundlich M; Kyriakides GK; Zilleruelo G; Strauss J; Esquenazi V; Miller J
    Transplantation; 1984 Jun; 37(6):612-6. PubMed ID: 6233771
    [No Abstract]   [Full Text] [Related]  

  • 40. Some characteristics of in vivo generated suppressor cells.
    Liburd EM; Marchuk LL; Pazderka VI; Dossetor JB
    Transplant Proc; 1979 Dec; 11(4):1830-2. PubMed ID: 161097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.